Related Experiment Video
Updated: Aug 9, 2026

Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus
Published on: March 8, 2012
Repression of HPV16 early region transcription by the E2 protein
Emiko Soeda1, Maureen C Ferran, Carl C Baker
1Laboratory of Cellular Oncology, National Cancer Institute, National Institutes of Health, MD 20892, USA.
Abstract:
HPV16 DNA is often integrated in cancers, disrupting the E1 or E2 genes. E2 can repress the E6/E7 promoter, but other models have been proposed to explain why integration promotes malignant progression. E1 and E2 are required for viral replication, and so genetic analysis of their role in transcriptional regulation is complex. Therefore, we developed an extrachromosomal vector containing HPV16 to undertake a genetic analysis of the E1 and E2 genes. We demonstrate that the E2 protein is primarily a transcriptional repressor when expressed from the virus. Furthermore, repression requires both the transactivation function of E2 and specific binding of E2 to the LCR. We find no evidence that the E1 protein directly modulates HPV16 gene expression. However, certain E1 mutations modulated transcription indirectly by altering splicing of E2 mRNA species. These data provide important insight into which E1 and E2 functions are optimal targets for anti-viral therapies.
Insights
The E2 protein from human papillomavirus type 16 (HPV16) acts as a transcriptional repressor, with its function dependent on E2 binding and transactivation. This research clarifies E1 and E2 roles, aiding anti-viral therapy development.
Area of Science:
- Molecular Virology
- Cancer Biology
- Transcriptional Regulation
Background:
- Human papillomavirus type 16 (HPV16) DNA integration into host genomes is common in cancers.
- Integration often disrupts viral E1 and E2 genes, crucial for replication and transcriptional control.
- The precise mechanisms by which HPV16 integration promotes cancer progression are not fully understood.
Purpose of the Study:
- To genetically analyze the roles of HPV16 E1 and E2 proteins in transcriptional regulation.
- To investigate the function of E2 as a repressor of the viral promoter.
- To explore the direct and indirect effects of E1 on HPV16 gene expression.
Main Methods:
- Development of an extrachromosomal vector system for HPV16 genetic analysis.
- Expression of HPV16 E1 and E2 proteins from the vector.
- Assessment of transcriptional regulation of HPV16 genes.
Main Results:
- HPV16 E2 protein functions primarily as a transcriptional repressor.
- E2-mediated repression requires both its transactivation domain and specific binding to the Long Control Region (LCR).
- HPV16 E1 protein does not directly modulate viral gene expression, but certain E1 mutations indirectly affect transcription by altering E2 mRNA splicing.
Conclusions:
- HPV16 E2 is a key transcriptional repressor, modulated by its DNA binding and transactivation functions.
- E1's role in transcription is indirect, primarily through influencing E2 mRNA processing.
- Understanding these E1 and E2 functions offers potential targets for novel anti-HPV therapies.
Related Concept Videos
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
RNA Polymerase II Accessory Proteins
Negative Regulator Molecules
Initiation of Translation
First, the initiator tRNA must be selected from the pool of elongator tRNAs by eukaryotic initiation factor 2 (eIF2). The initiator tRNA (Met-tRNAi) has conserved sequence elements including modified bases at...
Heterochromatin
Constitutive heterochromatin: It is a highly compact region of chromatin that is mostly concentrated in the centromere and telomere. Unlike euchromatin, the amino acid at 9th...
The Eukaryotic Promoter Region

